← Back to Screener
CareDx, Inc. (CDNA)
Price$22.42
Favorite Metrics
Price vs S&P 500 (26W)14.81%
Price vs S&P 500 (4W)-4.73%
Market Capitalization$1.04B
P/E Ratio (Annual)18.34x
All Metrics
P/CF (Annual)24.86x
Book Value / Share (Quarterly)$5.95
P/TBV (Annual)3.57x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)5.68%
Cash Flow / Share (Quarterly)$0.70
Price vs S&P 500 (YTD)-9.38%
Gross Margin (TTM)67.55%
Net Profit Margin (TTM)-5.62%
EPS (TTM)$-0.39
10-Day Avg Trading Volume0.57M
EPS Excl Extra (TTM)$-0.39
Revenue Growth (5Y)14.59%
EPS (Annual)$-0.40
ROI (Annual)-7.05%
Gross Margin (Annual)67.55%
Net Profit Margin (5Y Avg)-18.38%
Cash / Share (Quarterly)$3.48
P/E Basic Excl Extra (TTM)15.86x
Revenue Growth QoQ (YoY)25.19%
P/E Normalized (Annual)18.34x
ROA (Last FY)-5.17%
Revenue Growth TTM (YoY)13.79%
EBITD / Share (TTM)$-0.52
ROE (5Y Avg)-18.07%
Operating Margin (TTM)-8.10%
Cash Flow / Share (Annual)$0.70
P/B Ratio3.45x
P/B Ratio (Quarterly)3.20x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.58x
Net Interest Coverage (TTM)-15.50x
ROA (TTM)-4.80%
EV / EBITDA (TTM)18.41x
EPS Incl Extra (Annual)$-0.40
Current Ratio (Annual)2.86x
Quick Ratio (Quarterly)2.45x
3-Month Avg Trading Volume0.69M
52-Week Price Return-7.04%
EV / Free Cash Flow (Annual)27.63x
P/E Incl Extra (TTM)15.86x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.33
P/S Ratio (Annual)2.75x
Asset Turnover (Annual)0.92x
52-Week High$21.48
Operating Margin (5Y Avg)-20.34%
EPS Excl Extra (Annual)$-0.40
CapEx CAGR (5Y)-8.66%
Tangible BV CAGR (5Y)3.05%
26-Week Price Return18.80%
Quick Ratio (Annual)2.45x
13-Week Price Return-14.58%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)2.86x
Enterprise Value$979.384
Revenue / Share Growth (5Y)11.51%
Asset Turnover (TTM)0.85x
Book Value / Share Growth (5Y)1.15%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)5.33x
Pretax Margin (Annual)-5.55%
Cash / Share (Annual)$3.48
3-Month Return Std Dev61.81%
Gross Margin (5Y Avg)66.12%
Net Income / Employee (TTM)$-0
ROE (Last FY)-7.05%
Net Interest Coverage (Annual)-12.00x
EPS Basic Excl Extra (Annual)$-0.40
P/FCF (TTM)16.41x
Receivables Turnover (TTM)7.08x
EV / Free Cash Flow (TTM)27.63x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.39
Receivables Turnover (Annual)7.08x
ROI (TTM)-6.47%
P/S Ratio (TTM)2.75x
Pretax Margin (5Y Avg)-18.41%
Revenue / Share (Annual)$7.13
Tangible BV / Share (Annual)$5.33
Free OCF CAGR (5Y)8.97%
Price vs S&P 500 (52W)-36.87%
P/E Ratio (TTM)15.86x
Year-to-Date Return-6.74%
5-Day Price Return5.27%
EPS Normalized (Annual)$-0.40
ROA (5Y Avg)-10.95%
Net Profit Margin (Annual)-5.62%
Month-to-Date Return1.21%
Cash Flow / Share (TTM)$-1.42
EBITD / Share (Annual)$-0.52
Operating Margin (Annual)-8.10%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)24.86x
ROI (5Y Avg)-18.07%
P/E Excl Extra (TTM)15.86x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.39
P/TBV (Quarterly)3.57x
P/B Ratio (Annual)3.20x
Inventory Turnover (TTM)5.33x
Pretax Margin (TTM)-5.55%
Book Value / Share (Annual)$5.95
Price vs S&P 500 (13W)-15.27%
Beta2.46x
P/FCF (Annual)29.48x
Revenue / Share (TTM)$7.43
ROE (TTM)-6.47%
52-Week Low$10.96
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
3.86
3.93
3.93
Industry Peers — Health Services(20)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $22.42 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $196.11 |
LHLabcorp Holdings Inc. | 25.08x | 7.25% | 9.92% | 10.28% | $266.36 |
DGXQuest Diagnostics Inc. | 21.24x | 11.78% | 14.10% | 13.88% | $191.46 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $85.70 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $60.09 |
VCYTVeracyte, Inc. | 40.04x | 16.01% | 11.17% | 5.33% | $33.03 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $49.47 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.09 |
CSTLCastle Biosciences, Inc. Common Stock | 47.31x | 3.66% | -12.44% | -5.27% | $24.56 |
About
CareDx is a precision medicine company providing genomics-based testing solutions for transplant patients. Its primary products include AlloSure and AlloMap, diagnostic tests that monitor transplant function and rejection risk. The company generates most revenue from testing services in the United States, serving transplant recipients and caregivers throughout the patient journey.